Dr. Pavani Gonnabathula is a clinical pharmacology and toxicology expert with more than a decade of experience in pharmacokinetics, toxicology, PBPK/PBTK modeling, PK/PD, and model-informed product evaluation. She has held research roles with the U.S. FDA and CDC and has contributed to scientific work spanning drug development, environmental toxicology, human health risk assessment, and regulatory science.

Her expertise includes physiologically based pharmacokinetic modeling, toxicokinetic assessment, pediatric and maternal health-related exposure evaluation, developmental toxicology, and safety-focused scientific decision-making. Dr. Gonnabathula’s work emphasizes translating complex pharmacological and toxicological data into clear, evidence-based guidance to support safer therapeutic, environmental, and public health decisions. She is particularly interested in applying computational modeling, IVIVE, and regulatory science approaches to improve risk assessment and protect vulnerable populations, including children and pregnant individuals.